INTRAVENOUS IMMUNOGLOBULIN THERAPY FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY RECALCITRANT TO CONVENTIONAL THERAPY

被引：1
|
作者：
URVAL, K [1 ]
NELSON, RP [1 ]
COHEN, SR [1 ]
GOOD, RA [1 ]
机构：
[1] UNIV S FLORIDA,ALL CHILDRENS HOSP,DEPT PEDIAT,801 6TH ST S,ST PETERSBURG,FL 33701
来源：
SOUTHERN MEDICAL JOURNAL | 1991年 / 84卷 / 11期
关键词：
D O I：
10.1097/00007611-199111000-00024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1381 / 1384
页数：4
相关论文
共 50 条
  • [31] CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY - CONDUCTION FAILURE BEFORE AND DURING IMMUNOGLOBULIN OR PLASMA THERAPY
    VANDERMECHE, FGA
    VERMEULEN, M
    BUSCH, HFM
    BRAIN, 1989, 112 : 1563 - 1571
  • [32] Economic evaluation of subcutaneous versus intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy: a real-life study
    Piscitelli, Eugenia
    Massa, Marida
    De Martino, Bernardo Maria
    Serio, Carmela Simona
    Guglielmi, Gaspare
    Colacicco, Giovanni
    Tuccillo, Francesco
    Habetswallner, Francesco
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (E1) : E115 - E119
  • [33] MAINTENANCE THERAPY WITH SUBCUTANEOUS IMMUNOGLOBULIN IN PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY: A LONGTERM FOLLOWUP
    Harvey, Brittany
    Tucker, Natalie
    Hart, Adam
    Katzin, Lara
    Farias, Jerrica
    Jones, Nichole
    Dang, Samuel
    Gooch, Clifton
    Vu, Tuan
    MUSCLE & NERVE, 2016, 54 (03) : 575 - 575
  • [34] COST OF ILLNESS, COST OF IMMUNOGLOBULIN THERAPY AND THEIR DETERMINANTS IN CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY Reply
    Mengel, David
    Dodel, Richard
    Tackenberg, Bjoern
    MUSCLE & NERVE, 2019, 59 (03) : E23 - E23
  • [35] Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy
    Good, JL
    Chehrenama, M
    Mayer, RF
    Koski, CL
    NEUROLOGY, 1998, 51 (06) : 1735 - 1738
  • [36] Etanercept (Enbrel®) therapy for chronic inflammatory demyelinating polyneuropathy
    Chin, RL
    Sherman, WH
    Sander, HW
    Hays, AP
    Latov, N
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2003, 210 (1-2) : 19 - 21
  • [37] Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy
    Oztekin, N. Subutay
    Oztekin, M. F.
    Orhan, G.
    Ak, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 266 - 267
  • [38] The gut microbiome in intravenous immunoglobulin-treated chronic inflammatory demyelinating polyneuropathy
    Svacina, Martin K. R.
    Sprenger-Svacina, Alina
    Tsakmaklis, Anastasia
    Rueb, Alina M.
    Klein, Ines
    Wuestenberg, Hauke
    Fink, Gereon R.
    Lehmann, Helmar C.
    Vehreschild, Maria J. G. T.
    Farowski, Fedja
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (11) : 3551 - 3556
  • [39] AN N OF 1 TRIAL OF INTRAVENOUS IMMUNOGLOBULIN TREATMENT FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
    HANKEY, GJ
    TODD, AAM
    YAP, PL
    WARLOW, CP
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1994, 57 (09): : 1137 - 1137
  • [40] Nerve conduction studies (MCS) in patients with chronic inflammatory demyelinating polyneuropathy (CODP) treated with intravenous immunoglobulin therapy versus placebo
    Bril, Vera
    Katzberg, Hans
    Dalakas, Marinos
    Deng, Chunqin
    Donofrio, Peter
    Hanna, Kim
    Hartung, Hans
    Hughes, Richard
    Latov, Norman
    Merkies, Ingemar
    Van Doorn, Pieter
    NEUROLOGY, 2008, 70 (11) : A368 - A368
12345